April 18th 2024
Integration of prostate MRI may improve the balance of patient harms and benefits in prostate cancer screening.
Age, Race, and Ethnicity Representation Disparities Found in Patients Participating in aRCC Research
July 3rd 2023Researchers discovered age, race, and ethnicity representation disparities in patients taking part in research on advanced renal cell carcinoma (aRCC), further exemplifying how certain groups are underrepresented in clinical studies.
Read More
Webinar Gives Hope for New Liver Cancer Treatments, Clinical Trial Improvements
June 28th 2023A webinar presented by the Global Liver Institute highlighted areas of improvement needed in research for liver cancer, but also left listeners with hope for future treatments focused on strengthening immunity.
Read More
Travis Brewer Discusses Payer Initiatives to Improve Oncology Patient Outcomes
June 27th 2023Texas Oncology's Travis Brewer, vice president of payer relations, discusses how collaboration between primary care providers and oncologists can improve population health outcomes by focusing on payer initiatives and strategies.
Watch
Contemporary Care Patterns in the Management of Small Renal Masses
An investigation of management patterns after initial radiographic diagnosis of small renal masses showed that early urologist referral was associated with guideline-concordant care.
Read More
Addressing racial disparities in skin cancer involves education, understanding rates of risk and ethnicity, and knowledge of the different types of melanoma, which makes skin cancer disparities complex to attack, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
Watch
TPG, AmerisourceBergen Acquire OneOncology in Deal Valued at $2.1 Billion
April 20th 2023Under the transaction, TPG, an asset management firm, will acquire a majority interest in OneOncology and AmerisourceBergen will have a minority interest; OneOncology physician leaders and practices will retain minority interests as well.
Read More
Oncology Stakeholders Must Align in the Pursuit of Health Equity, Value-Based Care
April 18th 2023Coverage from the session of the Institute for Value-Based Medicine®, held in New York, New York, on February 8, 2023. The American Journal of Managed Care® presented the event in partnership with New York Cancer and Blood Specialists.
Read More
Dr Sancy Leachman Discusses Tailoring Genetic Testing for Melanoma to the Patient
April 16th 2023Each patient needs to weigh the benefits and risks of genetic testing for melanoma and have someone who can take the time to explain everything, including insurance risks, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
Watch
Dr Sashi Naidu: Financial Concerns Are a Constant Challenge in Community Oncology
April 9th 2023Sashi Naidu, MD, is director of research at Carolina Blood and Cancer Care Associates, where the No One Left Alone (NOLA) initiative is working to break down cancer health disparities among its patients and prevent care fragmentation.
Watch
Dr Ryan Huey Discusses the Necessity of Teamwork in Value-Based Oncology
April 7th 2023Ryan Huey, MD, gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas, discussed the vital roles multiple health care providers play in improving outcomes for patients with cancer.
Watch
Dr David Eagle: Health Equity Involves More Than Medical Care
April 2nd 2023Close to 80% of what influences how long someone is going to live is where and how they live, and we need to pay more attention to that or we’re not paying attention to everything that affects their lives, explained David A. Eagle, MD, of New York Cancer & Blood Specialists.
Watch
Dr Sancy Leachman Outlines a “Spectrum of Problems” Between Melanoma Detection and Treatment
March 30th 2023There is a “spectrum” of problems and obstacles in a patient’s way once melanoma has been detected before that patient sees the right physician and receives treatment, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
Watch
Pembrolizumab Receives Full Approval for Select Patients With MSI-H or dMMR Solid Tumors
March 29th 2023The FDA has granted full approval to pembrolizumab for the treatment of some patients with unresectable or metastatic microsatellite instability–high (MSI-H) or mismatch repair–deficient (dMMR) solid tumors that have progressed following previous treatment.
Read More
The FDA wants to discourage the use of single-arm trials for accelerated approvals of oncology drugs; Cigna’s review system allows doctors to reject claims without reading them, an investigation shows; US bishops want to restrict gender transition care in Catholic hospitals.
Read More
Samyukta Mullangi, MD, MBA, oncology fellow at Memorial Sloan Kettering Cancer Center and incoming medical director at Thyme Care, discussed how the transition to value-based care can contribute to operational and financial risks among oncology practices, and the effectiveness of care navigation platforms in addressing these concerns.
Read More
Manmeet Ahluwalia, MD, MBA, chief, Solid Tumor Medical Oncology; deputy director; and chief scientific officer at Miami Cancer Institute, spoke on the short- and long-term goals for Miami Cancer Institute’s Center for Equity in Cancer Care & Research in improving minority patient enrollment in clinical trials.
Watch
Nicolas Ferreyros: There Is Growing Recognition the 340B Program Is "Out of Control"
March 22nd 2023Growing bipartisan awareness of issues with the 340B drug pricing program will hopefully lead to reform, says Nicolas Ferreyros, BA, managing director of policy, advocacy, and communications at the Community Oncology Alliance.
Watch
There Is Something for Everyone to Do to Improve Health Equity, Says Oncology Consultants’ Wagner
March 22nd 2023Many people believe health equity is such a big issue that there is not much an individual practice can do to address it, explained Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy, Oncology Consultants of Houston.
Watch
Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
Read More
Dr Manmeet Ahluwalia on Improving Genomic Testing Disparities in Oncology
March 12th 2023Manmeet Ahluwalia, MD, MBA, chief, Solid Tumor Medical Oncology; deputy director; and chief scientific officer at Miami Cancer Institute, addressed disparities in genomic testing among minority patients with cancer, as well as equitable care strategies at his organization’s Center for Equity in Cancer Care & Research.
Watch